Tom Huizinga

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tom Huizinga. Retrieved from https://idiyas.com/inventor/tom-huizinga-v20yxfsb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Tom Huizinga: Innovator in Molecular Biology

Introduction

Tom Huizinga is a notable inventor in the field of molecular biology, particularly recognized for his contributions to the diagnosis of rheumatoid arthritis. His work focuses on innovative methods for detecting specific antibodies in patients, which can significantly enhance diagnostic accuracy.

Latest Patents

Tom Huizinga holds a patent titled "Compositions And Methods For The Diagnosis Of Rheumatoid Arthritis." This patent relates to methods for detecting anti-carbamylated protein (anti-CarP) antibodies in the serum of rheumatoid arthritis patients. Despite having 0 patents, his research has made a substantial impact in the medical field.

Career Highlights

Throughout his career, Tom has worked with prominent organizations such as Inova Diagnostics, Inc. and Leiden University Medical Center. His experience in these institutions has allowed him to develop and refine his innovative approaches to diagnosing rheumatoid arthritis.

Collaborations

Tom has collaborated with esteemed colleagues, including Michael Mahler and Leendert A Trouw. These partnerships have contributed to the advancement of research in molecular biology and the development of diagnostic methods.

Conclusion

Tom Huizinga's work in molecular biology exemplifies the importance of innovation in medical diagnostics. His contributions, particularly in the diagnosis of rheumatoid arthritis, highlight the potential for advancements in patient care through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…